| abstract |
Pharmaceutical composition suitable for once-daily administration, which composition comprises: (a) 2 mg to 12 mg of 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidin-2, 4-dione, optionally in the form of a pharmaceutically acceptable salt or solvate thereof; (b) 100 mg to 3000 mg of metformin or a pharmaceutically acceptable salt thereof; and (c) a pharmaceutically acceptable carrier; characterized in that the composition is designed to allow prolonged release of 5- [4- [2- (N-methyl-N |